Latest Swiss Market Index Stories
NEW YORK, Sept. 25, 2012 /PRNewswire/ -- IntraLinks® (NYSE: IL), a leading, global technology provider of inter-enterprise content management and collaboration solutions, today announced that Actelion Pharmaceuticals Ltd, an Allschwil/Basel, Switzerland headquartered biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative treatments to serve unmet medical needs, has selected IntraLinks Connect(SM) to streamline their documentation...
MALVERN, Pa. and LAVAL, Quebec, July 9, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and Actelion Pharmaceuticals Canada Inc. announced today that Auxilium was granted a Notice of Compliance (approval) by Health Canada for XIAFLEX(®) (collagenase clostridium histolyticum or CCH), a novel, first-in-class biologic for the treatment of Dupuytren's contracture in adults with a palpable cord in Canada. (Logo:...
MALVERN, Pa., and ALLSCHWIL/BASEL, Switzerland, Feb. 23, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and Actelion Pharmaceuticals Ltd. (SWX: ATLN.S) announced today that they have entered into a long-term partnership for the development, supply and commercialization of XIAFLEX® (collagenase clostridium histolyticum), a novel, first-in-class biologic for the potential treatment of Dupuytren's contracture and Peyronie's disease. Under the terms of the...
GENEVA, Nov. 17, 2010 /PRNewswire/ -- Weatherford announced that its shares will begin trading today on the SIX Swiss Exchange ("SIX") under the stock ticker WFT. Weatherford shares continue to be listed on the New York Stock Exchange and the NYSE Euronext. (Logo: http://photos.prnewswire.com/prnh/19990308/WEATHERFORDLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/19990308/WEATHERFORDLOGO) The inclusion of Weatherford's 758,446,637 registered shares into the Swiss Performance Index...
GENEVA, Nov. 12, 2010 /PRNewswire/ -- Weatherford announced today that the Swiss Exchange ("SIX") has approved the listing and trading of its shares on SIX starting 17 November 2010, under the stock ticker WFT. (Logo: http://photos.prnewswire.com/prnh/19990308/WEATHERFORDLOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/19990308/WEATHERFORDLOGO) The inclusion of the 758,446,637 registered shares of Weatherford into the benchmark SPI Index is expected to occur in a staggered manner over five...
LIBERTY CORNER, N.J., Feb. 23 /PRNewswire/ -- GeneraMedix, Inc. announced today that it has entered into a definitive agreement to sell its improved formulation of epoprostenol sodium for the intravenous treatment of pulmonary arterial hypertension (PAH) to Actelion LTD., a biopharmaceutical company with its headquarters in Allschwil/Basel, Switzerland. Financial terms of the deal were not disclosed. "This sale speaks directly to our company's ongoing commitment to serving the...
